Literature DB >> 8508557

Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro.

Z G Li1, V A Danis, P M Brooks.   

Abstract

Sex hormones have profound effects on immune responses and may influence the outcome of autoimmune diseases such as rheumatoid arthritis (RA). We investigated the effect of gonadal steroids on the production of interleukin-1 (IL-1) and IL-6, cytokines believed to be important in the pathogenesis of RA. Peripheral blood mononuclear cells (PBMCs) were isolated from healthy male donors and male patients with RA, and were stimulated with lipopolysaccharide (LPS) in the presence of different concentrations of 17-beta-estradiol, progesterone or testosterone. In studies of cells from normal male donors, 17-beta-estradiol at pharmacological concentrations (> or = 10(-6) M) enhanced IL-1 and IL-6 secretion as well as the production of cell-associated IL-1. Progesterone and testosterone at similar concentrations inhibited IL-1 secretion but had no significant effect on IL-6 secretion or on the production of cell-associated IL-1. In studies of male RA donors, 17-beta-estradiol failed to enhance IL-1 or IL-6 secretion and progesterone failed to inhibit IL-1 secretion. The inhibitory effects of testosterone, however, appeared to be similar to that in normal donors. It is suggested that 17-beta-estradiol may promote IL-1 and IL-6 production and release, while gestation hormone, progesterone, and testosterone may inhibit IL-1 release in vivo. These data may partly explain the gender and age differences in the incidence of RA and the development of the disease in men with low and androgen levels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508557

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  35 in total

Review 1.  Role of cytokines in testicular function.

Authors:  D B Hales; T Diemer; K H Hales
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

Review 2.  Estrogen and testosterone therapies in multiple sclerosis.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

Review 3.  Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  M Cutolo; A Sulli; B Villaggio; B Seriolo; S Accardo
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

4.  Immune function in healthy adolescents.

Authors:  J A Bartlett; S J Schleifer; M K Demetrikopoulos; B R Delaney; S C Shiflett; S E Keller
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

5.  Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings.

Authors:  Heather S L Jim; Jong Y Park; Jennifer Permuth-Wey; Maria A Rincon; Kristin M Phillips; Brent J Small; Paul B Jacobsen
Journal:  Brain Behav Immun       Date:  2012-03-28       Impact factor: 7.217

6.  Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans.

Authors:  H Bruunsgaard; A N Pedersen; M Schroll; P Skinhoj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 7.  Temperature regulation in women: Effects of the menstrual cycle.

Authors:  Fiona C Baker; Felicia Siboza; Andrea Fuller
Journal:  Temperature (Austin)       Date:  2020-03-22

8.  Testosterone and the metabolic syndrome.

Authors:  Vakkat Muraleedharan; T Hugh Jones
Journal:  Ther Adv Endocrinol Metab       Date:  2010-10       Impact factor: 3.565

9.  Tissue-specific transcription profiles of sex steroid biosynthesis enzymes and the androgen receptor.

Authors:  U Hoppe; P-M Holterhus; L Wünsch; D Jocham; T Drechsler; S Thiele; C Marschke; O Hiort
Journal:  J Mol Med (Berl)       Date:  2006-03-25       Impact factor: 4.599

10.  Monocyte proinflammatory cytokine release is higher and glucocorticoid sensitivity is lower in middle aged men than in women independent of cardiovascular risk factors.

Authors:  P H Wirtz; R von Känel; N Rohleder; J E Fischer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.